Investors

Welcome to our Investor Centre

Please click on the Profiles below to see more details on our other clients:

All of the information contained within this website has been compiled from sources believed to be reliable, but no warranty, expressed or implied, is given that the information is complete or accurate or that it is fit for a particular purpose. All such warranties are expressly disclaimed and excluded. Any opinions, recommendations and forecasts referred to are not those of Walbrook PR Limited but are expressly those of third parties, such as investment analysts and financial journalists. Such opinions, recommendations and forecasts may have been superseded and thus may not necessarily be the current opinions, recommendations and forecasts of the relevant analyst/broker. None of the content of this website should be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell, the securities of any listed Company mentioned or featured herein as it is for information only. Any recommendations referred to by third parties do not necessarily imply the suitability of particular securities for individual situations. The value of securities and the income from them may fluctuate. It should be remembered that past performance is not necessarily a guide to future performance. You are strongly advised to seek guidance from a professional investment adviser before entering into any contract to buy or sell any security featured herein. By reading this disclaimer, and ticking the box below, you confirm that you accept and understand its content, and that you shall not hold Walbrook PR Limited, its directors and staff nor any of its subsidiaries or connected companies liable for any loss that you may sustain should you decide to buy or sell any of the mentioned securities.

Novacyt S.A.

Company Profile

Company website
Sector
Medical Equipment and Services (Medical Equipment)
Description

Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing. 

Investor Access

26 Oct
Event information

The Company's AGM (rescheduled) will be held on 26 October 2023 at 1pm BST/2pm CEST at Hilton Paris Charles de Gaulle Airport.

Please check here for more information:

https://www.londonstockexchange.com/news-article/NCYT/notice-of-rescheduled-agm/16155159
Venue
Hilton Paris Charles de Gaulle Airport (8 Rue de Rome, 93290 Tremblay-en-France, France)
Time

Thursday 26 October at 1pm BST/2pm CEST

Financial Calendar
 Event Date
Year EndDecember
Half  Year EndJune
Preliminary Results*April
Interim Results*September
AGM*August

* Months based on previous announcements of this kind